Slovakia
Tuberculosis profile
Population  2012 5.4 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.034 (0.034–0.035) 0.63 (0.63–0.63)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0 (0–0)
Prevalence  (includes HIV+TB) 0.52 (0.22–0.93) 9.5 (4.1–17)
Incidence  (includes HIV+TB) 0.37 (0.32–0.42) 6.8 (5.9–7.7)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.02)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 96 (34) Relapse 25 (51)
Smear-negative 137 (49) Treatment after failure 0 (0)
Smear-unknown / not done 7 (3) Treatment after default 0 (0)
Extrapulmonary 39 (14) Other 24 (49)
Other 0 (0)      
Total new 279   Total retreatment 49  
           
Other (history unknown) 17        
Total new and relapse 304   Total cases notified 345  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.3 1.7 1.4
Age < 15 0 15 2
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 91   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 94  
Retreatment 88  
TB/HIV 2012 Number (%)
TB patients with known HIV status 322 (93)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0  
HIV-positive TB patients on antiretroviral therapy (ART) 0  
HIV-positive people screened for TB 196  
HIV-positive people provided with IPT 0  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0 (0–2.6) 3.7 (0.09–19)
MDR-TB cases among notified pulmonary
TB cases
0 (0–6) 2 (0–9)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 142 (95%) 27 (55%) 181
Laboratory-confirmed MDR-TB cases 0 1 4
Patients started on MDR-TB treatment     1
Financing TB control 2013
National TB programme budget (US$ millions) <1
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data